Candidemia

Candidemia is a Candida yeast infection of the bloodstream. It is one of the more serious fungal infections seen in hospital settings, carrying a significant mortality risk if treatment is delayed. Unlike superficial fungal infections of the skin or mucous membranes, candidemia spreads through the blood and can seed organs including the heart, kidneys, and eyes.

Medicine used to treat Candidemia

Vfend

Voriconazole

200mg

Developed to target serious fungal infections, this medication is indicated to address invasive aspergillosis and is utilized in systemic treatment protocols.

From $31.20 / tablet View

Who is at risk

Candidemia almost always occurs in people whose defences are already compromised. Common risk factors include prolonged stays in intensive care, central venous catheters, broad-spectrum antibiotic use, recent abdominal surgery, and conditions that weaken immunity such as haematological cancers or uncontrolled diabetes. Across South and Southeast Asia, rising rates of hospitalisation and increased use of invasive medical procedures have made candidemia an increasingly reported nosocomial infection in countries including India, Thailand, and the Philippines.

How candidemia is treated

Treatment relies on antifungals given intravenously or orally, depending on the species of Candida identified and the patient’s clinical status. Voriconazole is active against most Candida species and is used in selected cases, particularly where azole-susceptible strains are confirmed. The choice of agent is guided by culture and sensitivity results, since resistance patterns vary by region.

Anyone suspected of having candidemia, persistent fever, chills, or signs of organ involvement despite antibiotic therapy, should be evaluated in a hospital without delay.